["Results", "Quantitative results of TMT", "Protein enzymatic hydrolysis, peptide marker classification, and mass spectrometry were performed using TMT to identify and quantify protein segments and to analyze differentially expressed proteins. A total of 3320 unique peptide fragments were identified after inoculation with A. phaeospermum or sterile water, and 1791 proteins were quantified (Table\u00a01). Therefore, TMT-labeling combined with mass spectrometry could effectively isolate and identify proteins from the hybrid bamboo inoculated with either A. phaeospermum or sterile water. When considering proteins whose abundance significantly differed by more than 1.2 times (up\u2013down) (P value\u2009<\u20090.05), 102 differentially expressed proteins were identified in hybrid bamboo inoculated with A. phaeospermum in comparison with sterile water, of which 66 protein were upregulated while 36 were downregulated. The up-regulation and down-regulation parameters of differential proteins were shown in Table\u00a0S1. The results showed that the most up-regulated proteins belonged Thaumatin family, with the ID PH01000846G0450 and the fold-change value was 5.480. Moreover, the most down-regulated protein was Chlorophyll A-B binding protein, with the ID PH01000947G0680 and the fold-change value was 0.398.Table 1Protein identification results statistics.Identification resultUnique PeptideQuantified proteinUp-regulatedDown -regulatedSignificant difference in total proteinTotal332017916636102", "Protein identification results statistics.", "Identification result Unique Peptide Quantified protein Up-regulated Down -regulated Significant difference in total protein.", "Total 3320 1791 66 36 102.", "GO and KEGG analysis of differentially expressed proteins", "The GO28 function of the identified hybrid bamboo proteins was analyzed according to three aspects: biological process, molecular function, and cell component under two treatment conditions: inoculation of A. phaeospermum suspension and sterile water inoculation. The results (Fig.\u00a01) showed that the functional items (GO term) of protein enrichment in the cell component of hybrid bamboo was chloroplast, plastid part, chloroplast part, and chloroplast stroma. The functional items (GO term) where the proteins of hybrid bamboo were significantly enriched corresponded to molecular functions of oxidoreductase activity, tetrapyrrole binding, cofactor binding, and heme binding. The differentially expressed proteins of hybrid bamboo under different treatment conditions were significantly enriched in single-organism biosynthetic process (31 differentially expressed proteins) (Fig.\u00a01A). The differentially expressed proteins of hybrid bamboo under different treatment conditions were significantly enriched in cytoplasm (72 differentially expressed proteins) and intracellular organelle (71 differentially expressed proteins) in the cell component (Fig.\u00a01B). The differentially expressed proteins of hybrid bamboo under different treatment conditions were significantly enriched in cation binding (33 differentially expressed proteins) in the molecular function category (Fig.\u00a01C). The differential proteins annotation in the GO database were shown in Table\u00a0S2. KEGG29 enrichment analysis showed that the differential proteins of hybrid bamboo with the inoculation of A. phaeospermum and the sterile water were mainly concentrated in the metabolic pathways (Fig.\u00a02). Among them, the metabolic pathways for the significant enrichment of differentially expressed proteins were metabolic pathways (map01100) (34 differentially expressed proteins), the biosynthesis of secondary metabolites (map01110) (24 differentially expressed proteins), microbial metabolism in diverse environments (map01120) (14 differentially expressed proteins), carbon metabolism (map01200) (13 differentially expressed proteins), and the biosynthesis of amino acids (map01230) (11 differentially expressed proteins) (Table\u00a02). The differential proteins annotation in the KEGG database were shown in Table\u00a0S3. The top 10 signaling pathways with the most significant P value in the KEGG enrichment analysis are shown in Fig.\u00a03.Figure 1(A) The results of the biological processes with significant enrichment at Level 4. The horizontal axis represents the number of genes/proteins accumulated in each biological process. The P value is labeled after each bar. (B) The results of significant enrichment of cell components at Level 4. The horizontal axis represents the number of genes/proteins enriched by each cell component. The P value is labeled after each bar. (C) The results of molecular function enrichment at Level 4. The horizontal axis represents the number of genes/proteins enriched by each molecular function. The P value is labeled after each bar.Figure 2KEGG pathways were enriched at Level 4 between the treatment and control groups of hybrid bamboo. KEGG pathway classification indicating significantly enriched signaling pathways and their p values. The KEGG pathway is divided into the following categories in the KEGG database: (A) Metabolism, (B) Genetic Information Processing, (C) Environmental Information Processing, (D) Cellular Processes, (E) Organismal Systems, (H) Other and unknow.Table 2Signaling pathway response to protein based on GO and KEGG analysis.TermsCountP valueProtein IDs (Gene IDs)GO (gene ontology)(BP)Single-organism metabolic process318.99\u2009\u00d7\u200910\u221211PH01000011G2670|1.618939296;PH01000043G2150|1.543865433;P80089|1.874184585;UXS6|1.750945746;PH01000157G0430|1.585919766;CP12-2|1.799677343;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;WAXY|1.672246023;At1g62810|1.982103184;PH01000742G0250|1.721182159;Q43495|5.480307181;PH01000898G0600|1.965363594;PH01001498G0080|1.765636566;P29305|2.211106384;NDB2|1.523793191;CYP72A15|2.085602899;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;FER1|1.557846522;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;PAO|1.55076872;CAD5|1.611066513;VIT_19s0014g02480|2.117950844;LAC25|1.763531683;P83332|1.672999202;At1g74360|1.524451415;RPL9|0.575310035;PH01000024G2570|0.647692636;RPL24|0.571074195;PH01000137G0030|0.599065468;LPD1|0.565966308;NIR|0.650177682;CAP10A|0.501070054;UGT83A1|0.623960858;RPS10|0.618594113;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001219G0020|0.611022423;PH01001303G0370|0.653209586;Q02066|0.592333828;PH01001720G0230|0.649297598;At4g16580|0.563926869;PH01002342G0040|0.616356462;PSRP2|0.627572934;PH01004347G0010|0.641820982Small molecule metabolic process294.07\u2009\u00d7\u200910\u22126PH01000011G2670|1.618939296;P80089|1.874184585;UXS6|1.750945746;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;PH01000742G0250|1.721182159;Q43495|5.480307181;PH01001498G0080|1.765636566;P29305|2.211106384;PH01002248G0250|1.530194115;P80826|1.588424487;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;PH01100083G0010|1.848329913;VIT_19s0014g02480|2.117950844;RPL9|0.575310035;RPL24|0.571074195;NIR|0.650177682;CAP10A|0.501070054;UGT83A1|0.623960858;RPS10|0.618594113;P29308|0.398024362;PH01001219G0020|0.611022423;Q02066|0.592333828;PH01001720G0230|0.649297598;PSRP2|0.627572934(CC)Cytoplasm721.78\u2009\u00d7\u200910\u22126PH01000011G2670|1.618939296;PH01000041G1710|2.682780333;ASPG1|1.508196275;P80089|1.874184585;PH01000121G1130|1.598740941;UXS6|1.750945746;PH01000157G0430|1.585919766;SD25|1.609550724;CP12-2|1.799677343;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;WAXY|1.672246023;At1g62810|1.982103184;PATL3|1.665916623;BMY1|3.212227051;PH01000742G0250|1.721182159;Q43495|5.480307181;CYP-3|1.570124782;PH01000898G0600|1.965363594;PH01001131G0060|1.687345939;tlp|1.551620328;Zlp|1.673995861;PH01001498G0080|1.765636566;P29305|2.211106384;NDB2|1.523793191;CYP72A15|2.085602899;PH01002240G0140|1.500709346;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;FER1|1.557846522;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;FTA|1.509636399;PAO|1.55076872;PRP40A|1.884300818;BETV1L|1.835519874;RPL29|1.754881288;Os09g0442300|1.930133039;CCP1|1.634896552;At1g74360|1.524451415;CATHB2|1.915507292;RPL9|0.575310035;PH01000052G1130|0.441589629;PH01000071G1780|0.58635762;RPL24|0.571074195;PH01000137G0030|0.599065468;LPD1|0.565966308;PH01000239G0580|0.662960971;NIR|0.650177682;At4g12770|0.59063367;CAP10A|0.501070054;RPS10|0.618594113;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001219G0020|0.611022423;PH01001303G0370|0.653209586;TIM22-3|0.628426122;Q02066|0.592333828;PH01001720G0230|0.649297598;PH01002342G0040|0.616356462;RPS17|0.665658337;PSRP2|0.627572934;PH01004347G0010|0.641820982;Phyllostachys_edulis_newGene_36049|0.569207945;rps4|0.651115549;AGT1|0.595658203Intracellular organelle716.07\u2009\u00d7\u200910\u22124PH01000011G2670|1.618939296;PH01000041G1710|2.682780333;ASPG1|1.508196275;P80089|1.874184585;PH01000121G1130|1.598740941;UXS6|1.750945746;PH01000157G0430|1.585919766;SD25|1.609550724;CP12-2|1.799677343;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;WAXY|1.672246023;At1g62810|1.982103184;PATL3|1.665916623;BMY1|3.212227051;PH01000742G0250|1.721182159;Q43495|5.480307181;CYP-3|1.570124782;PH01000898G0600|1.965363594;PH01001131G0060|1.687345939;tlp|1.551620328;Zlp|1.673995861;PH01001498G0080|1.765636566;P29305|2.211106384;NDB2|1.523793191;CYP72A15|2.085602899;PH01002240G0140|1.500709346;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;FER1|1.557846522;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;PAO|1.55076872;PRP40A|1.884300818;BETV1L|1.835519874;RPL29|1.754881288;Os09g0442300|1.930133039;CCP1|1.634896552;At1g74360|1.524451415;CATHB2|1.915507292;RPL9|0.575310035;PH01000052G1130|0.441589629;PH01000071G1780|0.58635762;RPL24|0.571074195;PH01000137G0030|0.599065468;LPD1|0.565966308;PH01000239G0580|0.662960971;NIR|0.650177682;CAP10A|0.501070054;UGT83A1|0.623960858;RPS10|0.618594113;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001219G0020|0.611022423;PH01001303G0370|0.653209586;TIM22-3|0.628426122;Q02066|0.592333828;PH01001720G0230|0.649297598;PH01002342G0040|0.616356462;RPS17|0.665658337;PSRP2|0.627572934;PH01004347G0010|0.641820982;Phyllostachys_edulis_newGene_36049|0.569207945;rps4|0.651115549;AGT1|0.595658203(MF)Cation binding331.99\u2009\u00d7\u200910\u22125PH01000011G2670|1.618939296;PH01000043G2150|1.543865433;P80089|1.874184585;PH01000157G0430|1.585919766;At1g62810|1.982103184;BMY1|3.212227051;Q43495|5.480307181;PH01000898G0600|1.965363594;P29305|2.211106384;NDB2|1.523793191;CYP72A15|2.085602899;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;FER1|1.557846522;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;PAO|1.55076872;CAD5|1.611066513;VIT_19s0014g02480|2.117950844;PAP24|1.676756578;LAC25|1.763531683;PH01000003G3180|0.613648731;PH01000137G0030|0.599065468;LPD1|0.565966308;NIR|0.650177682;CAP10A|0.501070054;PH01000761G0570|0.656611514;Q02066|0.592333828;PH01001720G0230|0.649297598TermsCountP valueProtein Names (Gene Names)KEGG (Kyoto encyclopedia of genes and genomes) pathwaysMetabolic pathways342.86\u2009\u00d7\u200910\u22124PH01000011G2670|1.618939296;PH01000041G1710|2.682780333;PH01000043G2150|1.543865433;UXS6|1.750945746;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;At1g62810|1.982103184;Q43495|5.480307181;PH01000898G0600|1.965363594;PH01001498G0080|1.765636566;P29305|2.211106384;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;CAD5|1.611066513;VIT_19s0014g02480|2.117950844;PH01000071G1780|0.58635762;PH01000137G0030|0.599065468;LPD1|0.565966308;CAP10A|0.501070054;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001303G0370|0.653209586;Q02066|0.592333828;PH01001720G0230|0.649297598;PH01002342G0040|0.616356462;AGT1|0.595658203Biosynthesis of secondary metabolites248.27\u2009\u00d7\u200910\u22125PH01000041G1710|2.682780333;PH01000043G2150|1.543865433;PH01000157G0430|1.585919766;CSY2|1.614675989;TSB2|1.898726748;At1g62810|1.982103184;PH01000898G0600|1.965363594;P29305|2.211106384;P80826|1.588424487;PER70|2.036694586;ASP1|1.721142225;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;PAO|1.55076872;CAD5|1.611066513;LPD1|0.565966308;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001303G0370|0.653209586;Q02066|0.592333828;PH01002342G0040|0.616356462;AGT1|0.595658203Microbial metabolism in diverse environments143.22\u2009\u00d7\u200910\u22125PH01000011G2670|1.618939296;CSY2|1.614675989;PH01000290G0470|1.531403518;P29305|2.211106384;PH01002248G0250|1.530194115;P80826|1.588424487;ASP1|1.721142225;PH01005665G0070|1.648624898;PH01000137G0030|0.599065468;LPD1|0.565966308;NIR|0.650177682;P29308|0.398024362;Q02066|0.592333828;AGT1|0.595658203Carbon metabolism138.12\u2009\u00d7\u200910\u22126PH01000011G2670|1.618939296;CSY2|1.614675989;PH01000290G0470|1.531403518;P29305|2.211106384;PH01002248G0250|1.530194115;P80826|1.588424487;ASP1|1.721142225;PH01005665G0070|1.648624898;PH01000137G0030|0.599065468;LPD1|0.565966308;P29308|0.398024362;Q02066|0.592333828;AGT1|0.595658203Biosynthesis of amino acids111.29\u2009\u00d7\u200910\u22124PH01000041G1710|2.682780333;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;P29305|2.211106384;P80826|1.588424487;ASP1|1.721142225;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;P29308|0.398024362;Q02066|0.592333828Figure 3The top 10 KEGG signaling pathways with the most significant P value. The boundaries of P value 0.05 and 0.01 are marked.", "Figure 1(A) The results of the biological processes with significant enrichment at Level 4. The horizontal axis represents the number of genes/proteins accumulated in each biological process. The P value is labeled after each bar. (B) The results of significant enrichment of cell components at Level 4. The horizontal axis represents the number of genes/proteins enriched by each cell component. The P value is labeled after each bar. (C) The results of molecular function enrichment at Level 4. The horizontal axis represents the number of genes/proteins enriched by each molecular function. The P value is labeled after each bar.", "(A) The results of the biological processes with significant enrichment at Level 4. The horizontal axis represents the number of genes/proteins accumulated in each biological process. The P value is labeled after each bar. (B) The results of significant enrichment of cell components at Level 4. The horizontal axis represents the number of genes/proteins enriched by each cell component. The P value is labeled after each bar. (C) The results of molecular function enrichment at Level 4. The horizontal axis represents the number of genes/proteins enriched by each molecular function. The P value is labeled after each bar.", "Figure 2KEGG pathways were enriched at Level 4 between the treatment and control groups of hybrid bamboo. KEGG pathway classification indicating significantly enriched signaling pathways and their p values. The KEGG pathway is divided into the following categories in the KEGG database: (A) Metabolism, (B) Genetic Information Processing, (C) Environmental Information Processing, (D) Cellular Processes, (E) Organismal Systems, (H) Other and unknow.", "KEGG pathways were enriched at Level 4 between the treatment and control groups of hybrid bamboo. KEGG pathway classification indicating significantly enriched signaling pathways and their p values. The KEGG pathway is divided into the following categories in the KEGG database: (A) Metabolism, (B) Genetic Information Processing, (C) Environmental Information Processing, (D) Cellular Processes, (E) Organismal Systems, (H) Other and unknow.", "Signaling pathway response to protein based on GO and KEGG analysis.", "Terms Count P value Protein IDs (Gene IDs).", "GO (gene ontology).", "(BP).", "Single-organism metabolic process 31 8.99\u2009\u00d7\u200910\u221211 PH01000011G2670|1.618939296;PH01000043G2150|1.543865433;P80089|1.874184585;UXS6|1.750945746;PH01000157G0430|1.585919766;CP12-2|1.799677343;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;WAXY|1.672246023;At1g62810|1.982103184;PH01000742G0250|1.721182159;Q43495|5.480307181;PH01000898G0600|1.965363594;PH01001498G0080|1.765636566;P29305|2.211106384;NDB2|1.523793191;CYP72A15|2.085602899;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;FER1|1.557846522;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;PAO|1.55076872;CAD5|1.611066513;VIT_19s0014g02480|2.117950844;LAC25|1.763531683;P83332|1.672999202;At1g74360|1.524451415;RPL9|0.575310035;PH01000024G2570|0.647692636;RPL24|0.571074195;PH01000137G0030|0.599065468;LPD1|0.565966308;NIR|0.650177682;CAP10A|0.501070054;UGT83A1|0.623960858;RPS10|0.618594113;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001219G0020|0.611022423;PH01001303G0370|0.653209586;Q02066|0.592333828;PH01001720G0230|0.649297598;At4g16580|0.563926869;PH01002342G0040|0.616356462;PSRP2|0.627572934;PH01004347G0010|0.641820982.", "Small molecule metabolic process 29 4.07\u2009\u00d7\u200910\u22126 PH01000011G2670|1.618939296;P80089|1.874184585;UXS6|1.750945746;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;PH01000742G0250|1.721182159;Q43495|5.480307181;PH01001498G0080|1.765636566;P29305|2.211106384;PH01002248G0250|1.530194115;P80826|1.588424487;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;PH01100083G0010|1.848329913;VIT_19s0014g02480|2.117950844;RPL9|0.575310035;RPL24|0.571074195;NIR|0.650177682;CAP10A|0.501070054;UGT83A1|0.623960858;RPS10|0.618594113;P29308|0.398024362;PH01001219G0020|0.611022423;Q02066|0.592333828;PH01001720G0230|0.649297598;PSRP2|0.627572934.", "(CC).", "Cytoplasm 72 1.78\u2009\u00d7\u200910\u22126 PH01000011G2670|1.618939296;PH01000041G1710|2.682780333;ASPG1|1.508196275;P80089|1.874184585;PH01000121G1130|1.598740941;UXS6|1.750945746;PH01000157G0430|1.585919766;SD25|1.609550724;CP12-2|1.799677343;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;WAXY|1.672246023;At1g62810|1.982103184;PATL3|1.665916623;BMY1|3.212227051;PH01000742G0250|1.721182159;Q43495|5.480307181;CYP-3|1.570124782;PH01000898G0600|1.965363594;PH01001131G0060|1.687345939;tlp|1.551620328;Zlp|1.673995861;PH01001498G0080|1.765636566;P29305|2.211106384;NDB2|1.523793191;CYP72A15|2.085602899;PH01002240G0140|1.500709346;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;FER1|1.557846522;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;FTA|1.509636399;PAO|1.55076872;PRP40A|1.884300818;BETV1L|1.835519874;RPL29|1.754881288;Os09g0442300|1.930133039;CCP1|1.634896552;At1g74360|1.524451415;CATHB2|1.915507292;RPL9|0.575310035;PH01000052G1130|0.441589629;PH01000071G1780|0.58635762;RPL24|0.571074195;PH01000137G0030|0.599065468;LPD1|0.565966308;PH01000239G0580|0.662960971;NIR|0.650177682;At4g12770|0.59063367;CAP10A|0.501070054;RPS10|0.618594113;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001219G0020|0.611022423;PH01001303G0370|0.653209586;TIM22-3|0.628426122;Q02066|0.592333828;PH01001720G0230|0.649297598;PH01002342G0040|0.616356462;RPS17|0.665658337;PSRP2|0.627572934;PH01004347G0010|0.641820982;Phyllostachys_edulis_newGene_36049|0.569207945;rps4|0.651115549;AGT1|0.595658203.", "Intracellular organelle 71 6.07\u2009\u00d7\u200910\u22124 PH01000011G2670|1.618939296;PH01000041G1710|2.682780333;ASPG1|1.508196275;P80089|1.874184585;PH01000121G1130|1.598740941;UXS6|1.750945746;PH01000157G0430|1.585919766;SD25|1.609550724;CP12-2|1.799677343;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;WAXY|1.672246023;At1g62810|1.982103184;PATL3|1.665916623;BMY1|3.212227051;PH01000742G0250|1.721182159;Q43495|5.480307181;CYP-3|1.570124782;PH01000898G0600|1.965363594;PH01001131G0060|1.687345939;tlp|1.551620328;Zlp|1.673995861;PH01001498G0080|1.765636566;P29305|2.211106384;NDB2|1.523793191;CYP72A15|2.085602899;PH01002240G0140|1.500709346;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;FER1|1.557846522;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;PAO|1.55076872;PRP40A|1.884300818;BETV1L|1.835519874;RPL29|1.754881288;Os09g0442300|1.930133039;CCP1|1.634896552;At1g74360|1.524451415;CATHB2|1.915507292;RPL9|0.575310035;PH01000052G1130|0.441589629;PH01000071G1780|0.58635762;RPL24|0.571074195;PH01000137G0030|0.599065468;LPD1|0.565966308;PH01000239G0580|0.662960971;NIR|0.650177682;CAP10A|0.501070054;UGT83A1|0.623960858;RPS10|0.618594113;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001219G0020|0.611022423;PH01001303G0370|0.653209586;TIM22-3|0.628426122;Q02066|0.592333828;PH01001720G0230|0.649297598;PH01002342G0040|0.616356462;RPS17|0.665658337;PSRP2|0.627572934;PH01004347G0010|0.641820982;Phyllostachys_edulis_newGene_36049|0.569207945;rps4|0.651115549;AGT1|0.595658203.", "(MF).", "Cation binding 33 1.99\u2009\u00d7\u200910\u22125 PH01000011G2670|1.618939296;PH01000043G2150|1.543865433;P80089|1.874184585;PH01000157G0430|1.585919766;At1g62810|1.982103184;BMY1|3.212227051;Q43495|5.480307181;PH01000898G0600|1.965363594;P29305|2.211106384;NDB2|1.523793191;CYP72A15|2.085602899;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;FER1|1.557846522;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;PAO|1.55076872;CAD5|1.611066513;VIT_19s0014g02480|2.117950844;PAP24|1.676756578;LAC25|1.763531683;PH01000003G3180|0.613648731;PH01000137G0030|0.599065468;LPD1|0.565966308;NIR|0.650177682;CAP10A|0.501070054;PH01000761G0570|0.656611514;Q02066|0.592333828;PH01001720G0230|0.649297598.", "Terms Count P value Protein Names (Gene Names).", "KEGG (Kyoto encyclopedia of genes and genomes) pathways.", "Metabolic pathways 34 2.86\u2009\u00d7\u200910\u22124 PH01000011G2670|1.618939296;PH01000041G1710|2.682780333;PH01000043G2150|1.543865433;UXS6|1.750945746;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;At1g62810|1.982103184;Q43495|5.480307181;PH01000898G0600|1.965363594;PH01001498G0080|1.765636566;P29305|2.211106384;PH01002248G0250|1.530194115;P80826|1.588424487;PER70|2.036694586;ASP1|1.721142225;P50477|1.572109245;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;CAD5|1.611066513;VIT_19s0014g02480|2.117950844;PH01000071G1780|0.58635762;PH01000137G0030|0.599065468;LPD1|0.565966308;CAP10A|0.501070054;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001303G0370|0.653209586;Q02066|0.592333828;PH01001720G0230|0.649297598;PH01002342G0040|0.616356462;AGT1|0.595658203.", "Biosynthesis of secondary metabolites 24 8.27\u2009\u00d7\u200910\u22125 PH01000041G1710|2.682780333;PH01000043G2150|1.543865433;PH01000157G0430|1.585919766;CSY2|1.614675989;TSB2|1.898726748;At1g62810|1.982103184;PH01000898G0600|1.965363594;P29305|2.211106384;P80826|1.588424487;PER70|2.036694586;ASP1|1.721142225;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;Sb03g046810|1.723109056;PH01100083G0010|1.848329913;PAO|1.55076872;CAD5|1.611066513;LPD1|0.565966308;PH01000761G0570|0.656611514;P29308|0.398024362;PH01001303G0370|0.653209586;Q02066|0.592333828;PH01002342G0040|0.616356462;AGT1|0.595658203.", "Microbial metabolism in diverse environments 14 3.22\u2009\u00d7\u200910\u22125 PH01000011G2670|1.618939296;CSY2|1.614675989;PH01000290G0470|1.531403518;P29305|2.211106384;PH01002248G0250|1.530194115;P80826|1.588424487;ASP1|1.721142225;PH01005665G0070|1.648624898;PH01000137G0030|0.599065468;LPD1|0.565966308;NIR|0.650177682;P29308|0.398024362;Q02066|0.592333828;AGT1|0.595658203.", "Carbon metabolism 13 8.12\u2009\u00d7\u200910\u22126 PH01000011G2670|1.618939296;CSY2|1.614675989;PH01000290G0470|1.531403518;P29305|2.211106384;PH01002248G0250|1.530194115;P80826|1.588424487;ASP1|1.721142225;PH01005665G0070|1.648624898;PH01000137G0030|0.599065468;LPD1|0.565966308;P29308|0.398024362;Q02066|0.592333828;AGT1|0.595658203.", "Biosynthesis of amino acids 11 1.29\u2009\u00d7\u200910\u22124 PH01000041G1710|2.682780333;CSY2|1.614675989;TSB2|1.898726748;PH01000290G0470|1.531403518;P29305|2.211106384;P80826|1.588424487;ASP1|1.721142225;PH01005469G0070|1.910034876;PH01005665G0070|1.648624898;P29308|0.398024362;Q02066|0.592333828.", "Figure 3The top 10 KEGG signaling pathways with the most significant P value. The boundaries of P value 0.05 and 0.01 are marked.", "The top 10 KEGG signaling pathways with the most significant P value. The boundaries of P value 0.05 and 0.01 are marked.", "PPI Analysis", "The PPI analysis chart (Fig.\u00a04) was drawn by using Cytoscape software (version 3.7.1. URL link: cytoscape.org.), based on the gene-interaction network that incorporates protein-protein interaction results along with other pieces of evidence like fold-change, KEGG term enrichment, and biological process enrichment. The most prominently upregulated proteins with high connectivity between the treatment group and the control group are shown in red, and metabolic pathways in dark blue. Among them, D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (ID: PH01000290G0470), Transaldolase (ID:PH01005665G0070), Indole-3-glycerol phosphate synthase (ID: PH01005469G0070), and Glutamine amidotransferase class-I, Peptidase C26 (ID: PH01000041G1710) were upregulated, and participated in several significantly enriched metabolic pathways through other significant protein/gene interactions in the treatment group and control group of hybrid bamboo (Table\u00a03).Figure 4PPI network map of differential proteins in the treatment and control groups of hybrid bamboo.(It was drawn by using Cytoscape software. Its version was 3.7.1 and URL linkwas cytoscape.org. Round node represents the protein/gene (for fold change analysis, red indicates upregulation, green indicates downregulation), rectangular node represents the KEGG pathway/biological process, significant p value is expressed by the yellow\u2013blue gradient, yellow indicates the p value is smaller, blue indicates the p value is larger.Table 3High connectivity differential protein information in PPI.Protein IDDescriptionKEGG pathwaysPH01000290G0470LysosomeCarbon metabolismMicrobial metabolism in diverse environmentsBiosynthesis of antibioticsGlycine, serine, and threonine metabolismPhenylalanine, tyrosine, and tryptophan biosynthesisBiosynthesis of amino acidsPH01005665G0070LysosomeCarbon metabolismBiosynthesis of antibioticsMicrobial metabolism in diverse environmentsBiosynthesis of secondary metabolitesBiosynthesis of amino acidsPH01005469G0070Biosynthesis of antibioticsBiosynthesis of secondary metabolitesBiosynthesis of amino acidsPhenylalanine, tyrosine, and tryptophan biosynthesisPH01000041G1710Biosynthesis of antibioticsBiosynthesis of secondary metabolitesBiosynthesis of amino acidsPhenylalanine, tyrosine, and tryptophan biosynthesis", "Figure 4PPI network map of differential proteins in the treatment and control groups of hybrid bamboo.(It was drawn by using Cytoscape software. Its version was 3.7.1 and URL linkwas cytoscape.org. Round node represents the protein/gene (for fold change analysis, red indicates upregulation, green indicates downregulation), rectangular node represents the KEGG pathway/biological process, significant p value is expressed by the yellow\u2013blue gradient, yellow indicates the p value is smaller, blue indicates the p value is larger.", "PPI network map of differential proteins in the treatment and control groups of hybrid bamboo.(It was drawn by using Cytoscape software. Its version was 3.7.1 and URL linkwas cytoscape.org. Round node represents the protein/gene (for fold change analysis, red indicates upregulation, green indicates downregulation), rectangular node represents the KEGG pathway/biological process, significant p value is expressed by the yellow\u2013blue gradient, yellow indicates the p value is smaller, blue indicates the p value is larger.", "High connectivity differential protein information in PPI.", "Protein ID Description KEGG pathways.", "PH01000290G0470  Lysosome.", "Carbon metabolism.", "Microbial metabolism in diverse environments.", "Biosynthesis of antibiotics.", "Glycine, serine, and threonine metabolism.", "Phenylalanine, tyrosine, and tryptophan biosynthesis.", "Biosynthesis of amino acids.", "PH01005665G0070  Lysosome.", "Carbon metabolism.", "Biosynthesis of antibiotics.", "Microbial metabolism in diverse environments.", "Biosynthesis of secondary metabolites.", "Biosynthesis of amino acids.", "PH01005469G0070  Biosynthesis of antibiotics.", "Biosynthesis of secondary metabolites.", "Biosynthesis of amino acids.", "Phenylalanine, tyrosine, and tryptophan biosynthesis.", "PH01000041G1710  Biosynthesis of antibiotics.", "Biosynthesis of secondary metabolites.", "Biosynthesis of amino acids.", "Phenylalanine, tyrosine, and tryptophan biosynthesis.", "LC-PRM/MS statistical analysis and PRM validation of 11 differential proteins", "In order to verify the accuracy of TMT and LC-MS/MS data analysis, LC\u2013PRM/MS was used to analyze the candidate peptides of the 11 target proteins (These 11 peptides are unique peptides of each protein), basing on the up-regulated and down-regulated differentially expressed proteins in the GO and KEGG databases, and combing with functional annotation information. The Skyline analysis results of each peptides are shown Fig.\u00a0S1 and include the chromatographic peak contrast map (Skyline analysis map). After the Skyline analysis of 3\u20135 sub-ions with high abundance and as continuous as possible in the secondary mass spectrometry, the peak area of each target peptide (Table\u00a0S4) was obtained. The ionic peak area of the corresponding peptide is presented in Table\u00a0S5. The results of quantitative analysis of target peptide fragments in different samples are shown in Table\u00a0S6. The quantitative results of PRM (Table\u00a04) showed that 10 of the 11 candidate proteins were similar to the trend of TMT. They showed a fold change\u2009>\u20091.2 times with a significance of less than 0.05. The trend consistency between PRM validation and TMT data was 91% demonstrating that the data obtained by TMT combined with LC-MS/MS in this experiment were reliable. Among them, there results for differentially expressed proteins Pyruvate phosphate dikinase (ID:PH01000011G2670), Alcohol dehydrogenase GroES-like domain (ID:PH01000043G2150), Ribulose bisphosphate carboxylase (ID: PH01000137G0030), Peroxidase (ID: PH01000761G0570, PH01000898G0600), Clp protease (ID: PH01001219G0020), DnaJ domain (ID: PH01002240G0140), Indole-3-glycerol phosphate synthase (ID: PH01005469G0070), and PEP/pyruvate binding domain (ID: PH01002248G0250) (ID: PH01100083G0010)were similar to those obtained with TMT. All proteome PRM data of 2 samples of hybrid bamboo was deposited in the integrated proteome resources under the accession number, respectively.Table 4Quantitative information table of 11 candidate proteins by PRM and TMT.Protein IDProtein NamePeptide SequenceTreatment (A. phaeospermum Inoculation)Control (sterile water)Fold ChangeTMTFold Change PRMConsistent with the quantitative trend of TMT dataPH01000011G2670Pyruvate phosphate dikinase, PEP/pyruvate binding domain; PEP-utilising enzymeTPEDLDAMR18800935.746482210.9151.622.90YesPH01000043G2150Alcohol dehydrogenase GroES-like domainANVEQYCNK9216705.2672813699.212.683.28YesPH01000137G0030Ribulose bisphosphate carboxylase, Ribulose-1,5-bisphosphate carboxylase small subunitANVEQYCNK95884188.96112125351.90.600.86YesPH01000742G0250\u2014DAEGAGIYGSQGR8081460.32610726002.861.720.75NoPH01000761G0570PeroxidaseNNPSDIDPSLNPSYAK1347740.7172437134.9470.660.55YesPH01000898G0600PeroxidaseMGNINPLTGTAGQIR605242794183946954.61.973.29YesPH01001219G0020Clp proteaseSSSSYSQHR1356342.2891881885.6750.610.72YesPH01002240G0140HSCB C-terminal oligomerisation domain; DnaJ domainEAVNEASDSQTLEK4627480.9991873152.0261.502.47YesPH01002248G0250PEP-utilising enzyme, Pyruvate phosphate dikinase, PEP/pyruvate binding domain; PEP-utilising enzyme,ELCSETGADQEDALAR14857013.634716898.71.533.15YesPH01005469G0070Indole-3-glycerol phosphate synthaseDIEEELGAPR2008165.2371062576.021.911.89YesPH01100083G0010\u2014YFSAAASQALDTAER14580393.993450921.4361.854.23Yes", "Quantitative information table of 11 candidate proteins by PRM and TMT.", "Protein ID Protein Name Peptide Sequence Treatment (A. phaeospermum Inoculation) Control (sterile water) Fold ChangeTMT Fold Change PRM Consistent with the quantitative trend of TMT data.", "PH01000011G2670 Pyruvate phosphate dikinase, PEP/pyruvate binding domain; PEP-utilising enzyme TPEDLDAMR 18800935.74 6482210.915 1.62 2.90 Yes.", "PH01000043G2150 Alcohol dehydrogenase GroES-like domain ANVEQYCNK 9216705.267 2813699.21 2.68 3.28 Yes.", "PH01000137G0030 Ribulose bisphosphate carboxylase, Ribulose-1,5-bisphosphate carboxylase small subunit ANVEQYCNK 95884188.96 112125351.9 0.60 0.86 Yes.", "PH01000742G0250 \u2014 DAEGAGIYGSQGR 8081460.326 10726002.86 1.72 0.75 No.", "PH01000761G0570 Peroxidase NNPSDIDPSLNPSYAK 1347740.717 2437134.947 0.66 0.55 Yes.", "PH01000898G0600 Peroxidase MGNINPLTGTAGQIR 605242794 183946954.6 1.97 3.29 Yes.", "PH01001219G0020 Clp protease SSSSYSQHR 1356342.289 1881885.675 0.61 0.72 Yes.", "PH01002240G0140 HSCB C-terminal oligomerisation domain; DnaJ domain EAVNEASDSQTLEK 4627480.999 1873152.026 1.50 2.47 Yes.", "PH01002248G0250 PEP-utilising enzyme, Pyruvate phosphate dikinase, PEP/pyruvate binding domain; PEP-utilising enzyme, ELCSETGADQEDALAR 14857013.63 4716898.7 1.53 3.15 Yes.", "PH01005469G0070 Indole-3-glycerol phosphate synthase DIEEELGAPR 2008165.237 1062576.02 1.91 1.89 Yes.", "PH01100083G0010 \u2014 YFSAAASQALDTAER 14580393.99 3450921.436 1.85 4.23 Yes."]